抗高血压药的研究进展与临床应用评价

被引:8
作者
范治国 [1 ]
刘治安 [2 ]
机构
[1] 重庆北部新区高新园人民医院
[2] 广东东莞东华医院药剂科
关键词
D O I
暂无
中图分类号
R544.1 [高血压];
学科分类号
100201 [内科学];
摘要
<正>高血压(Hypertention)是一个渐进性的,由复杂和相互关联着的病因学引起的心血管症状。常伴有脂肪和糖代谢紊乱,及心、脑、肾和眼视网膜等器官功能性或器质性病变,即器官重塑为特征的全身性疾病。抗高血压药又称降压药,指能
引用
收藏
页码:4011 / 4013
页数:3
相关论文
共 6 条
[1]
Renin inhibition in hypertension [J].
Gradman, Alan H. ;
Kad, Rishi .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (05) :519-528
[2]
Aliskiren [J].
Kappert, K. ;
Unger, T. ;
Kintscher, U. .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (24) :1308-1312
[3]
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial [J].
Andersen, Karl ;
Weinberger, Myron H. ;
Egan, Brent ;
Constance, Christian M. ;
Ali, Mohammed A. ;
Jine, James ;
Keefe, Deborah L. .
JOURNAL OF HYPERTENSION, 2008, 26 (03) :589-599
[4]
Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction [J].
Ishani, A ;
Weinhandl, E ;
Zhao, ZH ;
Gilbertson, DT ;
Collins, AJ ;
Yusuf, S ;
Herzog, CA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) :391-399
[5]
Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study*.[J].A. H. Barnett.Acta Diabetologica.2005, 1
[6]
Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: Results of a randomized trial [J].
Mugellini, A ;
Dobovisek, J ;
Planinc, D ;
Cremonesi, G ;
Fogari, R .
CLINICAL THERAPEUTICS, 2004, 26 (09) :1419-1426